Whole-exome sequencing has explored that 79% of patients with deep-infiltrating endometriosis had some harboring oncogenic driver mutations, such as ARID1A, KRAS, PIK3CA, and PPP2R1A [58]. Here, KRAS is linked to endometriosis.